Tirofiban
Cerebral Edema
Second Affiliated Hospital, School of Medicine, Zhejiang UniversitySmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Cerebral Edema cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Sodium Aescinate The Second Hospital of Hebei Medical University | Phase 4 | BB |
Conivaptan Jesse Corry | Phase 2 | B |
DEXAMETHASONE Jon Pérez Bárcena | Phase 3 | B |
Famotidine University of Florida | Phase 2 | B |
Ketorolac Tromethamine University of Florida | Phase 2 | B |
View all 18 →
Same molecule, other indications
Tirofiban is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →